Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Deneberg

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Haematologica|January 27, 2022
A risk score based on real-world data to predict early death in acute promyelocytic leukemiaAlbin Österroos, Tânia Maia, Anna Eriksson, et al.
Haematologica|August 25, 2022
Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implicationsChrister Nilsson, Fredrika Linde, Erik Hulegårdh, et al.
Haematologica|September 8, 2009
Single nucleotide polymorphism genomic arrays analysis of t(8;21) acute myeloid leukemia cellsTadayuki Akagi, Lee-Yung Shih, Seishi Ogawa, et al.
Journal of Internal Medicine|August 8, 2022
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trialMartin Jädersten, Ingrid Lilienthal, Nikolaos Tsesmetzis, et al.
Leukemia|March 24, 2020
Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 studyPau Montesinos, Gail J Roboz, Claude-Eric Bulabois, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Validation of guidelines for genetic investigation of myeloid neoplasms with germline predisposition: results from a prospective cohort studyBianca Tesi, Anna Robelius, Berivan Baskin, et al.
Blood|April 5, 2023
Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic optionMonika Dolinska, Huan Cai, Alma Månsson, et al.
Nature|July 8, 2026
Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemiaYotaro Ochi, Markus Liew-Littorin, Yasuhito Nannya, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Haematologica|January 27, 2022
A risk score based on real-world data to predict early death in acute promyelocytic leukemiaAlbin Österroos, Tânia Maia, Anna Eriksson, et al.
Haematologica|August 25, 2022
Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implicationsChrister Nilsson, Fredrika Linde, Erik Hulegårdh, et al.
Haematologica|September 8, 2009
Single nucleotide polymorphism genomic arrays analysis of t(8;21) acute myeloid leukemia cellsTadayuki Akagi, Lee-Yung Shih, Seishi Ogawa, et al.
Journal of Internal Medicine|August 8, 2022
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trialMartin Jädersten, Ingrid Lilienthal, Nikolaos Tsesmetzis, et al.
Leukemia|March 24, 2020
Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 studyPau Montesinos, Gail J Roboz, Claude-Eric Bulabois, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Validation of guidelines for genetic investigation of myeloid neoplasms with germline predisposition: results from a prospective cohort studyBianca Tesi, Anna Robelius, Berivan Baskin, et al.
Blood|April 5, 2023
Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic optionMonika Dolinska, Huan Cai, Alma Månsson, et al.
Nature|July 8, 2026
Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemiaYotaro Ochi, Markus Liew-Littorin, Yasuhito Nannya, et al.
Pageof 3